Keryx Biopharma (KERX) Releases Zerenex Abstracts Into ASN Meeting; Shares Rise
Tweet
Share
E-mailGet Alerts KERX Hot Sheet
Join SI Premium – FREE
Keryx Biopharmaceuticals (Nasdaq: KERX) is up over 15 percent following release of abstracts for Zerenex, which will be presented at the American Society of Nephrology meeting. The meeting will take place November 5th through 10th in Atlanta, Ga.
The abstract Supplement from the meeting can be downloaded here. It's 24.8-MB in size and pdf format).
The abstract Supplement from the meeting can be downloaded here. It's 24.8-MB in size and pdf format).
Create E-mail Alert Related Categories
FDA, Insiders' Blog, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
